Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Blastocyst Culture Using Time-lapse in Good Prognosis IVF Patients and Elective Single Embryo Transfer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01773603
Recruitment Status : Terminated (No statistical difference observed for outcomes.)
First Posted : January 23, 2013
Last Update Posted : January 23, 2013
Sponsor:
Information provided by (Responsible Party):
Dr. Murat Çetinkaya, Memorial Sisli Hospital, Istanbul

Brief Summary:

Choosing the best embryo for transfer has become the major challenge in in vitro fertilization (IVF). Morphology alone is obviously not enough and time-lapse incubation has added embryo development kinetics as another selection criterion.

This study was designed to select for the top blastocyst to be replaced, while increasing the pregnancy chance, with the local legislation regulating the number of embryos to be transferred and to establish a morphokinetic standard to be used in our clinical setting.


Condition or disease Intervention/treatment Phase
Infertility Device: Embryoscope Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 64 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Blastocyst Culture Using Time-lapse in Good Prognosis IVF Patients and Elective Single Embryo Transfer
Study Start Date : December 2011
Actual Primary Completion Date : June 2012
Actual Study Completion Date : July 2012

Arm Intervention/treatment
No Intervention: Conventional incubation
Five-day embryo culture in conventional incubators
Active Comparator: Embryoscope
Five-day embryo culture in embryoscope which is an incubator with a built-in camera
Device: Embryoscope
Five-day embryo culture in embryoscope which is an incubator with a built-in camera
Other Name: Time-lapse monitoring of human embryos in Embryoscope




Primary Outcome Measures :
  1. Blastocyst formation rate [ Time Frame: 5th day of embryonic development ]

Secondary Outcome Measures :
  1. Clinical pregnancy rate [ Time Frame: 7th week of pregnancy ]
    Clinical pregnancy was defined as the presence of a gestational sac detected on ultrasound 3 weeks after the first βhCG test, which was performed 14 days after oocyte retrieval.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients in their first or second ART treatment cycle
  • no recurrent spontaneous abortions
  • age<35 years
  • BMI<28 kg/m2
  • ≥8 oocytes retrieved

Exclusion Criteria:

  • severe endometriosis
  • polycystic ovary syndrome
  • hydrosalpynx
  • uterine pathology
  • severe male factor (presenting less than 5 million motile sperm cells in total in the ejaculate)
  • very severe morphological sperm defects (mainly globozoospermic or macrocephalic samples)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01773603


Locations
Layout table for location information
Turkey
Sisli Memorial Hospital
Istanbul, Turkey, 34385
Sponsors and Collaborators
Dr. Murat Çetinkaya
Investigators
Layout table for investigator information
Study Director: Semra Kahraman, MD, Prof Sisli Memorial Hospital

Layout table for additonal information
Responsible Party: Dr. Murat Çetinkaya, R&D Laboratory Manager, Memorial Sisli Hospital, Istanbul
ClinicalTrials.gov Identifier: NCT01773603    
Other Study ID Numbers: MC0405
IMH2013-1 ( Other Identifier: Sisli Memorial Hospital )
First Posted: January 23, 2013    Key Record Dates
Last Update Posted: January 23, 2013
Last Verified: January 2013
Keywords provided by Dr. Murat Çetinkaya, Memorial Sisli Hospital, Istanbul:
Time-lapse
morphokinetics
blastocyst transfer
eSET
Additional relevant MeSH terms:
Layout table for MeSH terms
Infertility
Genital Diseases, Male
Genital Diseases, Female